3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Small Cell Lung Carcinoma
2
Radiation Injuries
2
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Memory Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Peripheral Blood Stem Cell Transplantation
38
fludarabine phosphate
36
Cyclophosphamide
31
Mycophenolic Acid
28
Cyclosporine
25
Whole-Body Irradiation
24
Tacrolimus
22
Busulfan
18
Antilymphocyte Serum
18
Radiotherapy
16
Methotrexate
16
Filgrastim
14
Etoposide
13
Methylprednisolone
10
Lenalidomide
10
Bortezomib
10
Vorinostat
9
Melphalan
9
Flow Cytometry
9
Rituximab
8
Gemcitabine
8
Cord Blood Stem Cell Transplantation
7
Bexarotene
7
pembrolizumab
6
mogamulizumab
6
Alemtuzumab
6
tanespimycin
5
fludarabine
5
aldesleukin
5
Transplantation
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sezary Syndrome
×
Lithium
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts